Association between tumor mutations and meningioma recurrence in Grade I/II disease-Reference-Cited by-同舟云学术

Association between tumor mutations and meningioma recurrence in Grade I/II disease

Published:2022-12-09 Issue: Volume:9 Page:70-81
ISSN:2331-4737
Container-title:Oncoscience
language:en
Short-container-title:Oncoscience

Author:

Dullea Jonathan T.¹,Vasan Vikram¹,Rutland John W.¹,Gill Corey M.¹,Chaluts Danielle¹,Ranti Daniel¹,Ellis Ethan²,Subramanium Varun¹,Arrighi-Allisan Annie¹,Kinoshita Yayoi³,McBride Russell B.³⁴,Bederson Joshua¹,Donovan Michael³,Sebra Robert²⁵,Umphlett Melissa³,Shrivastava Raj K.¹

Affiliation:

1. Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA

2. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA

3. Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA

4. The Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY 10129, USA

5. Sema4, A Mount Sinai Venture, Stamford, CT 06902, USA

Publisher

Impact Journals, LLC

Subject

Cancer Research,Oncology

Reference32 articles.

1. Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. Neuro Oncol. 2020; 22:iv1–96. https://doi.org/10.1093/neuonc/noaa200. PMID:33123732

2. Marciscano AE, Stemmer-Rachamimov AO, Niemierko A, Larvie M, Curry WT, Barker FG 2nd, Martuza RL, McGuone D, Oh KS, Loeffler JS, Shih HA. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. J Neurosurg. 2016; 124:106–14. https://doi.org/10.3171/2015.1.JNS142228. PMID:26274991

3. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016; 131:803–20. https://doi.org/10.1007/s00401-016-1545-1. PMID:27157931

4. Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, Ligon KL, Palescandolo E, Van Hummelen P, Ducar MD, Raza A, Sunkavalli A, Macconaill LE, et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet. 2013; 45:285–89. https://doi.org/10.1038/ng.2526. PMID:23334667

5. Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K, Avşar T, Li J, Murray PB, Henegariu O, Yilmaz S, Günel JM, Carrión-Grant G, et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science. 2013; 339:1077–80. https://doi.org/10.1126/science.1233009. PMID:23348505

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NF2 mutation associated with accelerated time to recurrence for older patients with atypical meningiomas;British Journal of Neurosurgery;2023-04-25